RxDoctor Payments Data
★ My doctorsLook up a doctor →

Dennis Disch

Cardiovascular Disease · Niles, MINPI 1003812926

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,304 of the $2,864 with a category attached, or 80.4%. 19 manufacturers reported payments, led by Medtronic at 48.8% of the total. 2024 is the largest year on record at $1,386, 5.4 times the $256 reported in 2019. That places this record below the midpoint for cardiovascular disease clinicians in MI, where the typical reported total is $2,775.

$2,864in general payments, 2019–2025

Across 91 payments — averaging $31.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • Novartis$438
  • Johnson & Johnson$316
  • Lantheus Medical Imaging, Inc.$119
  • Edwards Lifesciences$94
  • Abbott$87
  • plus $411 from 13 others

What the payments were for

  • Travel & lodging$56020%
  • Food & beverage$2,30480%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)15$1,399
Novartis32$438
Johnson & Johnson18$316
Lantheus Medical Imaging, Inc.1$119
Edwards Lifesciences1$94
Abbott2$87
Amgen1$66
Boehringer Ingelheim2$54
Amarin Pharma, Inc.2$34
Alnylam Pharmaceuticals Inc.2$33
Actelion Pharmaceuticals US, Inc.2$33
Sanofi-aventis U.S. LLC2$32
Bayer2$31
E.r. Squibb & Sons, L.L.C.2$31
Pfizer2$25
Boston Scientific1$22
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)2$20
Merck1$17
Astellas Pharma US Inc1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,864 in reported general payments places this provider in the 50th percentile of 760 cardiovascular disease providers in Michigan.

See all cardiovascular disease providers in Michigan →

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban52$59,968
XareltoRivaroxaban16$17,910
Repatha SureclickEvolocumab15$11,089
Metoprolol Succinate55$979
ClopidogrelClopidogrel Bisulfate13$405
Atorvastatin Calcium27$392
Metoprolol Tartrate30$365
Losartan Potassium27$271
Amlodipine Besylate28$189
Torsemide15$165
Carvedilol18$162

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$25$59,96852 claims
Johnson & JohnsonXarelto$316$17,91016 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 760 cardiovascular disease providers in Michigan.

Other cardiovascular disease in Niles

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →